The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

And here’s what else you need to know to Start Your Week Smart . Your day is busy. 5 Things is your one-stop shop for the ...

The FDA approved Eli Lilly's Zepbound as the first drug for obesity-linked moderate-to-severe sleep apnea, potentially transforming treatment options for 80 million Americans.

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.

There are many breakthroughs in medicine regarding the treatment of obstructive sleep apnea, and a weight loss drug might ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...

Obesity is not just a weight issue — it’s a chronic ... abnormalities in the lipid profile, fatty liver and obstructive sleep apnea (presenting as fatigue, sleepiness, headaches, decreased ...

However, she enjoyed how the meals switched up every week. When she first started on her weight loss journey she was on the seven-day meal plan. She's lost 33kg. Picture: Supplied Less than a ...

Zepbound (tirzepatide) provided a 47% greater relative weight loss compared to Wegovy (semaglutide ... hypertension, dyslipidemia, obstructive sleep apnea (OSA) or cardiovascular disease, who did not ...

Obstructive sleep apnea (OSA) is a serious and increasingly prevalent condition among the elderly, marked by frequent interruptions in breathing during sleep because of airway blockage. As age ...